BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 7479679)

  • 1. The effects of glucagon-like peptide-I (GLP-I) on hormone secretion from isolated human pancreatic islets.
    Fehmann HC; Hering BJ; Wolf MJ; Brandhorst H; Brandhorst D; Bretzel RG; Federlin K; Göke B
    Pancreas; 1995 Aug; 11(2):196-200. PubMed ID: 7479679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of glucagon-like peptide-1 (GLP-1) receptor and the effect of GLP-1-(7-36) amide on insulin release by pancreatic islets during rat ontogenic development.
    García-Flores M; Zueco JA; Alvarez E; Blázquez E
    Eur J Biochem; 2001 Feb; 268(3):514-20. PubMed ID: 11168389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptidergic regulation of maturation of the stimulus-secretion coupling in fetal islet beta cells.
    Sjöholm A; Sandberg E; Ostenson CG; Efendić S
    Pancreas; 2000 Apr; 20(3):282-9. PubMed ID: 10766455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas.
    Qader SS; Håkanson R; Rehfeld JF; Lundquist I; Salehi A
    Regul Pept; 2008 Feb; 146(1-3):230-7. PubMed ID: 17942170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
    Parkes DG; Pittner R; Jodka C; Smith P; Young A
    Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.
    Farilla L; Bulotta A; Hirshberg B; Li Calzi S; Khoury N; Noushmehr H; Bertolotto C; Di Mario U; Harlan DM; Perfetti R
    Endocrinology; 2003 Dec; 144(12):5149-58. PubMed ID: 12960095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line.
    Fehmann HC; Habener JF
    FEBS Lett; 1991 Feb; 279(2):335-40. PubMed ID: 1672112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
    Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S
    Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of glucagon-like peptide-I (GLP-I) and galanin in insulin (beta TC-1)- and somatostatin (RIN T3)-secreting cells and evidence that both peptides have no receptors on glucagon (INR1G9)-secreting cells.
    Fehmann HC; Janssen M; Göke B
    Acta Diabetol; 1995 Oct; 32(3):176-81. PubMed ID: 8590787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of stimulators such as GLP-1, PACAP, and nicotinamide on glucose-stimulated insulin secretion from porcine pancreatic endocrine cells in long-term culture.
    Sato A; Wang PC; Ohgawara H
    Pancreas; 2002 Jul; 25(1):86-93. PubMed ID: 12131777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulinotropic effects of cholecystokinin, gastric inhibitory polypeptide and glucagon-like peptide-1 during perifusion of short-term cultured canine isolated islets.
    van der Burg MP; Guicherit OR; Frölich M; Gooszen HG
    Regul Pept; 1995 Dec; 60(1):61-7. PubMed ID: 8747785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of glucagon-like peptide 1 insulinotropic action by succinic acid dimethyl ester.
    Leclercq-Meyer V; Malaisse WJ
    Life Sci; 1996; 58(14):1195-9. PubMed ID: 8614271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
    Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
    Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure-function relationship of GLP-1 related peptides in the endocrine function of the canine pancreas.
    Ohneda A; Ohneda K; Ohneda M; Koizumi F; Ohashi S; Kawai K; Suzuki S
    Tohoku J Exp Med; 1991 Nov; 165(3):209-21. PubMed ID: 1807008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7--36) amide.
    Heller RS; Aponte GW
    Am J Physiol; 1995 Dec; 269(6 Pt 1):G852-60. PubMed ID: 8572216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multifaceted potential of glucagon-like peptide-1 as a therapeutic agent.
    Lam NT; Kieffer TJ
    Minerva Endocrinol; 2002 Jun; 27(2):79-93. PubMed ID: 11961501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of GLP-I and leptin at rat pancreatic B-cells: effects on insulin secretion and signal transduction.
    Fehmann HC; Bode HP; Ebert T; Karl A; Göke B
    Horm Metab Res; 1997 Nov; 29(11):572-6. PubMed ID: 9479558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic beta-cells.
    Miura Y; Matsui H
    Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1001-9. PubMed ID: 14534075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of glucagonlike peptide I-(7-36) on release of insulin, glucagon, and somatostatin by rat pancreatic islet cell monolayer cultures.
    D'Alessio DA; Fujimoto WY; Ensinck JW
    Diabetes; 1989 Dec; 38(12):1534-8. PubMed ID: 2573553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1 stimulates insulin secretion but not phosphoinositide hydrolysis from islets desensitized by prior exposure to high glucose or the muscarinic agonist carbachol.
    Zawalich WS; Zawalich KC
    Metabolism; 1996 Feb; 45(2):273-8. PubMed ID: 8596502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.